Smart Implantable Pumps

Smart Implantable Pumps Market Outlook

The global smart implantable pumps market is anticipated to reach USD 6.7 billion by 2035, growing at a compound annual growth rate (CAGR) of approximately 9.2% from 2025 to 2035. This market growth can be primarily attributed to the rising prevalence of chronic diseases that require long-term medication management, advancements in technologies facilitating enhanced patient monitoring, and a growing demand for minimally invasive treatment options. Additionally, the increasing focus on personalized medicine and the integration of smart technologies such as wireless connectivity and mobile applications are further propelling the market. As healthcare providers seek efficient and effective solutions to improve patient outcomes, smart implantable pumps are becoming an integral part of treatment protocols across various applications.

Growth Factor of the Market

The smart implantable pumps market is experiencing significant growth due to various factors, one of which is the increasing incidence of chronic conditions such as diabetes, chronic pain, and neurological disorders that necessitate precise medication delivery. Furthermore, the technological advancements in implantable devices that allow for real-time monitoring and data collection have greatly improved patient adherence to therapy and treatment outcomes. The integration of digital health technologies including mobile apps and remote monitoring systems has enabled healthcare professionals to stay informed about patients' conditions and adjust treatment plans proactively. Additionally, the aging population worldwide, who often face multiple health challenges, is driving the demand for more sophisticated medical devices capable of delivering tailored therapies. Lastly, the growing trend toward outpatient care, driven by healthcare policies that emphasize cost-effective treatment options, is also boosting the market for smart implantable pumps.

Key Highlights of the Market

• The market is projected to exhibit a CAGR of 9.2% from 2025 to 2035.
• North America dominates the market, accounting for over 40% of the global share.
• Programmable implantable pumps are the fastest-growing product type.
• The oncology application segment is expected to witness substantial growth.
• Technological advancements, particularly in wireless connectivity, are transforming product offerings.

By Product Type

Programmable Implantable Pumps:

Programmable implantable pumps are designed to deliver medication in a controlled and adjustable manner, allowing healthcare providers to tailor dosing schedules to meet individual patient needs. These pumps often feature built-in software that can be programmed according to the dosage requirements of the patient, providing flexibility in treatment. Their ability to automate the delivery of medication helps in managing conditions that require constant medication levels, such as chronic pain or diabetes. The growing prevalence of such chronic conditions, coupled with technological advancements that enhance the functionality of programmable pumps, is driving their demand in the market.

Non-Programmable Implantable Pumps:

Non-programmable implantable pumps are typically designed for specific medication delivery without the flexibility of dosage adjustments. These pumps are usually simpler in design and are suitable for patients with stable conditions where medication dosages do not require frequent changes. The simplicity and reliability of non-programmable pumps make them an attractive option for certain applications, particularly in regions where advanced programmable options may not be readily accessible. Despite their limitations, the demand for non-programmable pumps remains strong, particularly in developing markets where cost-effectiveness is a key consideration.

Remote-Controlled Implantable Pumps:

Remote-controlled implantable pumps are revolutionizing patient care by allowing patients or healthcare providers to adjust the pump settings without needing invasive procedures. This remote capability enhances patient comfort and allows for timely adjustments based on real-time feedback. As patients increasingly seek more control over their healthcare management, the demand for remote-controlled devices is expected to grow. These pumps are particularly beneficial in managing pain and chronic conditions where precise control over medication delivery is crucial. The development of user-friendly interfaces and mobile applications to control these pumps is further encouraging their adoption.

Sensor-Enhanced Implantable Pumps:

Sensor-enhanced implantable pumps incorporate advanced sensing technologies that monitor various physiological parameters, allowing for automated adjustments in medication delivery based on real-time data. These innovations enhance the efficacy and safety of treatment regimens, as they can respond dynamically to changes in a patient's condition. The integration of sensors also enables healthcare providers to collect valuable data, which can be analyzed to optimize treatment outcomes and improve patient adherence. The increasing focus on personalized medicine is driving up the demand for sensor-enhanced pumps, as they enable tailored therapy based on individual physiological responses.

Smartphone-Connected Implantable Pumps:

Smartphone-connected implantable pumps leverage mobile technology to enhance patient engagement and facilitate communication between patients and healthcare providers. These devices allow patients to monitor their medication delivery in real time, receive alerts, and communicate with their care teams through dedicated mobile applications. The convenience and accessibility offered by smartphone connectivity are highly attractive to tech-savvy patients and are contributing to increased adherence to treatment plans. As digital health becomes more prevalent, the demand for smartphone-connected implantable pumps is expected to grow significantly.

By Application

Pain Management:

The pain management segment is a significant application area for smart implantable pumps, particularly for patients suffering from chronic pain conditions. These pumps deliver analgesics directly into the cerebrospinal fluid or targeted areas, providing effective relief without the systemic side effects associated with oral medications. With the increasing awareness of opioid addiction and the need for alternative pain management solutions, the demand for implantable pumps for pain management is on the rise. The segment's growth is further fueled by advancements in pump technology, which allow for more precise delivery of medications and better patient outcomes.

Spasticity Management:

Smart implantable pumps are increasingly used in spasticity management for patients with neurological disorders such as multiple sclerosis and cerebral palsy. By delivering medications like baclofen directly into the intrathecal space, these pumps can significantly reduce muscle stiffness and improve mobility. The ability to fine-tune medication delivery based on individual patient responses ensures optimal outcomes. As the focus on neurological rehabilitation grows, the demand for implantable pumps in spasticity management is expected to rise, making it a key area of application in the market.

Oncology:

The oncology application segment is witnessing significant growth, as smart implantable pumps provide a method for the targeted delivery of chemotherapeutic agents. By administering medications directly into the tumor site or bloodstream, these pumps enhance the efficacy of cancer treatments while minimizing systemic toxicity. The increasing incidence of cancer globally necessitates innovative and effective treatment options, thereby driving the demand for smart implantable pumps in oncology. Additionally, advancements in technology that allow for better monitoring and management of treatment regimens are further supporting this segment's growth.

Gastroenterology:

In the field of gastroenterology, smart implantable pumps are used for the delivery of medications to manage conditions such as inflammatory bowel disease and gastroesophageal reflux disease. The ability to provide localized treatment directly to the affected areas improves therapeutic efficacy and patient comfort. As gastrointestinal disorders become more prevalent, the demand for advanced treatment methods, including implantable pumps, is expected to grow. The ongoing research and development aimed at improving the performance and reliability of these devices will contribute to the expansion of this application segment.

Cardiology:

Smart implantable pumps are also making significant inroads into cardiology, particularly for the management of heart failure and other cardiovascular diseases. These pumps facilitate the continuous delivery of medications that help regulate heart function and manage symptoms. The growing prevalence of cardiovascular diseases worldwide is a driving force behind the increased adoption of smart implantable pumps in this sector. With advancements in design and technology aimed at improving patient outcomes, the cardiology segment is poised for considerable growth in the coming years, contributing to the overall expansion of the smart implantable pumps market.

By Distribution Channel

Hospitals:

Hospitals play a crucial role as distribution channels for smart implantable pumps, given their capacity to offer a wide range of medical services and specialty care. The presence of trained medical professionals and advanced healthcare facilities allows for proper patient management and follow-up after implantation. Hospitals are often the first point of contact for patients requiring smart implantable pumps, thus driving their demand through patient referrals and treatment protocols. As the healthcare landscape continues to evolve, hospitals remain a dominant channel, accounting for a significant portion of overall sales in the market.

Specialty Clinics:

Specialty clinics, focusing on specific medical areas such as pain management, oncology, or gastroenterology, are increasingly becoming pivotal distribution channels for smart implantable pumps. These clinics often provide tailored services and therapies, making them attractive for patients seeking specialized care. The expertise and experience found in specialty clinics facilitate the effective use of implantable pumps, leading to better patient outcomes and higher satisfaction. As patient preferences shift towards specialized care, the demand for smart implantable pumps through these clinics is expected to grow significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) serve as alternative distribution channels for smart implantable pumps, especially for outpatient procedures. These centers are equipped to handle less complex surgeries and are often more cost-effective than hospitals, making them an attractive option for patients. The shift towards outpatient care is driving the growth of ASCs, as they provide convenient and focused services. As more procedures involving implantable pumps move to outpatient settings, ASCs are becoming increasingly important in the distribution of these devices.

Online Stores:

The rise of e-commerce has led to a growing trend of purchasing medical devices, including smart implantable pumps, through online stores. This distribution channel offers patients and healthcare providers an accessible and convenient way to procure devices, often at competitive prices. Online platforms provide comprehensive product information and customer reviews, assisting users in making informed decisions. As the digital landscape continues to expand, the market for smart implantable pumps via online stores is expected to grow, offering new opportunities for manufacturers and retailers alike.

Others:

Other distribution channels for smart implantable pumps include pharmacies and medical supply stores, which cater to specific patient needs and preferences. These channels often provide additional services such as consultation and support, enhancing the overall patient experience. The variety of distribution channels ensures that patients have access to the devices they need, regardless of their location or healthcare setting. As the demand for smart implantable pumps continues to rise, these alternative distribution channels will play a vital role in meeting market needs.

By Technology

Bluetooth-enabled Implantable Pumps:

Bluetooth-enabled implantable pumps are gaining momentum in the market due to their capability for seamless data transmission between the device and external devices such as smartphones and tablets. This technological advancement enhances patient engagement by allowing real-time monitoring and remote adjustments of medication delivery. Bluetooth connectivity also facilitates the collection of vital data that can be shared with healthcare providers, which is essential for optimizing treatment plans. The convenience and accessibility offered by Bluetooth technology are driving its adoption in various applications, particularly in chronic disease management.

Wi-Fi-enabled Implantable Pumps:

Wi-Fi-enabled implantable pumps represent a significant advance in medical device technology, allowing for constant connectivity and real-time data exchange. These pumps can transmit information regarding medication delivery, battery status, and patient health metrics directly to healthcare providers, improving overall management and oversight. The ability to access patient data remotely contributes to timely interventions and enhances patient safety. As healthcare continues to embrace digital solutions, the demand for Wi-Fi-enabled implantable pumps is expected to expand, offering new possibilities for patient care and monitoring.

RFID-enabled Implantable Pumps:

RFID-enabled implantable pumps utilize Radio Frequency Identification technology to facilitate automatic identification and tracking of the device within the medical setting. This technology enhances patient safety by ensuring proper identification of devices and preventing medication errors. The use of RFID can also streamline inventory management for healthcare providers, reducing the chances of shortages or overstocking. The growing emphasis on safety and efficiency in healthcare practices is driving the demand for RFID-enabled implantable pumps, making them an attractive option for both patients and providers.

Near Field Communication (NFC) Implantable Pumps:

NFC implantable pumps are at the forefront of technological innovation, allowing for quick and secure communication between the pump and nearby devices. This proximity-based technology simplifies the process of data exchange, enabling healthcare providers to monitor patient data and make necessary adjustments with minimal effort. The ease of use and enhanced security features associated with NFC technology are appealing to both patients and healthcare professionals. As the digital health landscape evolves, the adoption of NFC-enabled devices in the smart implantable pumps market is expected to grow significantly.

Wireless Charging Implantable Pumps:

Wireless charging implantable pumps are revolutionizing the way these devices are powered, eliminating the need for invasive battery replacement procedures. This technology allows patients to charge their devices externally, making the management of implantable pumps less cumbersome. The convenience of wireless charging is particularly beneficial for patients with chronic conditions requiring long-term use of implantable devices. As manufacturers continue to innovate and improve the efficiency of wireless charging technologies, the market for these pumps is likely to expand as patients seek improved usability and reliability.

By Near Field Communication

NFC-enabled Implantable Pumps:

NFC-enabled implantable pumps utilize Near Field Communication technology to facilitate secure and quick communication with compatible devices. This advanced feature allows healthcare providers to easily access patient data and device status through simple interactions, enhancing patient monitoring and management. The technology's focus on security and ease of use is particularly beneficial in clinical settings where time is of the essence. As healthcare professionals increasingly rely on technology for patient management, the demand for NFC-enabled implantable pumps is expected to rise, transforming how therapies are delivered and monitored.

By Region

The North American region is projected to dominate the smart implantable pumps market, accounting for over 40% of the global market share. The presence of advanced healthcare infrastructure, high disposable income, and a strong emphasis on research and innovation significantly contribute to the robust growth of this market segment. Additionally, the increasing prevalence of chronic conditions and the rising demand for effective pain management solutions are expected to drive the adoption of smart implantable pumps in North America. The region is also witnessing rapid advancements in medical technology, further solidifying its position in the global market.

Europe is anticipated to be the second-largest market for smart implantable pumps, driven by the increasing awareness of advanced medical devices and a growing aging population requiring chronic disease management. The region is expected to exhibit a CAGR of approximately 8.4% during the forecast period, reflecting the rising demand for sophisticated implantable solutions. Additionally, favorable healthcare policies and regulations promoting the adoption of innovative medical devices contribute to the growth of the smart implantable pumps market in Europe. As manufacturers continue to invest in research and development, the market will likely see the introduction of new and improved devices, enhancing competition and expanding the overall market landscape.

Opportunities

The smart implantable pumps market presents numerous opportunities for growth, particularly in the realm of technological innovation. With the rapid advancement of digital health technologies, there is a growing potential for the integration of smart implantable pumps with telehealth platforms, enabling remote monitoring and management of patients. This capability not only increases patient convenience but also enhances the ability of healthcare providers to manage chronic conditions more effectively. The ongoing development of artificial intelligence and data analytics also presents an opportunity for manufacturers to create more sophisticated algorithms that can optimize medication delivery based on real-time patient data, leading to improved treatment outcomes.

Moreover, the increasing global focus on personalized medicine is creating a favorable environment for the expansion of smart implantable pumps. As healthcare systems shift towards more individualized treatment approaches, the demand for devices that can be tailored to specific patient needs is expected to rise. Manufacturers that prioritize customization and flexibility in their product offerings are likely to capture a larger share of the market. Additionally, emerging markets in Asia-Pacific and Latin America present significant growth opportunities as healthcare infrastructure improves and access to advanced medical technologies increases. This trend is likely to drive the adoption of smart implantable pumps in these regions, further contributing to the overall market expansion.

Threats

Despite the promising growth prospects for the smart implantable pumps market, several threats could hinder progress. One major concern is the high cost associated with the development and implementation of advanced implantable technologies. These costs may limit accessibility for healthcare providers, particularly in developing regions where budget constraints are prevalent. In addition, the complexity of the technology involved may deter some healthcare professionals from adopting these devices, leading to slower market penetration. The potential for device malfunctions or complications also poses a threat, as any adverse events can lead to patient dissatisfaction and loss of trust in implantable therapies.

Moreover, the regulatory landscape surrounding medical devices is becoming increasingly stringent, with rigorous requirements for approval and monitoring. This tightening of regulations can slow down the introduction of new products to market and could potentially limit innovation. Manufacturers must navigate these challenges carefully to maintain compliance while also addressing the dynamic needs of healthcare providers and patients. Lastly, competition from alternative therapies and non-invasive treatment options could pose a threat, as patients increasingly seek less invasive solutions for their medical needs. This evolving landscape necessitates continuous innovation and adaptation from manufacturers to remain competitive.

Competitor Outlook

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Horizon Therapeutics
• Smiths Medical
• Bayer AG
• Teleflex Incorporated
• Fresenius Kabi AG
• Insulet Corporation
• Dexcom, Inc.
• Hälsokraft
• Flowonix Medical, Inc.
• Roche Diabetes Care
• Cambridge Medical Robotics

The competitive landscape of the smart implantable pumps market is characterized by the presence of several key players that are continuously striving to innovate and enhance their product offerings. Established companies like Medtronic and Abbott Laboratories lead the market with a diverse range of implantable pump technologies and applications. These companies invest heavily in research and development to improve the functionality and performance of their devices, ensuring they remain at the forefront of the industry. Furthermore, collaborations between these major players and healthcare providers are becoming increasingly common, allowing for better integration of technology into treatment protocols.

Emerging companies such as Insulet Corporation and Flowonix Medical, Inc. are also making significant strides in the smart implantable pumps market, focusing on niche applications and innovative technologies such as smartphone connectivity and wireless charging. These companies are often more agile and can quickly adapt to changing market demands, which allows them to capture the attention of healthcare providers looking for the latest advancements. Additionally, the growing trend of startups entering the market with unique value propositions is contributing to a dynamic competitive environment, fostering innovation and pushing established players to enhance their offerings.

Key companies in the smart implantable pumps market are also working on expanding their global presence to tap into emerging markets with high growth potential. For instance, companies like Boston Scientific Corporation and Johnson & Johnson are focusing on expanding their footprint in Asia-Pacific and Latin America, where advances in healthcare infrastructure and increasing investment in medical technology are creating lucrative opportunities. These efforts are supported by strategic partnerships, acquisitions, and collaborations with local healthcare providers and distributors, facilitating access to a broader customer base and enhancing market reach.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Bayer AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Dexcom, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fresenius Kabi AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hälsokraft
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Insulet Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Roche Diabetes Care
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Horizon Therapeutics
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Teleflex Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Flowonix Medical, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cambridge Medical Robotics
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson (Ethicon)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Smart Implantable Pumps Market, By Technology
    • 6.1.1 Bluetooth-enabled Implantable Pumps
    • 6.1.2 Wi-Fi-enabled Implantable Pumps
    • 6.1.3 RFID-enabled Implantable Pumps
    • 6.1.4 Near Field Communication (NFC) Implantable Pumps
    • 6.1.5 Wireless Charging Implantable Pumps
  • 6.2 Smart Implantable Pumps Market, By Application
    • 6.2.1 Pain Management
    • 6.2.2 Spasticity Management
    • 6.2.3 Oncology
    • 6.2.4 Gastroenterology
    • 6.2.5 Cardiology
  • 6.3 Smart Implantable Pumps Market, By Product Type
    • 6.3.1 Programmable Implantable Pumps
    • 6.3.2 Non-Programmable Implantable Pumps
    • 6.3.3 Remote-Controlled Implantable Pumps
    • 6.3.4 Sensor-Enhanced Implantable Pumps
    • 6.3.5 Smartphone-Connected Implantable Pumps
  • 6.4 Smart Implantable Pumps Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Online Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Smart Implantable Pumps Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Smart Implantable Pumps market is categorized based on

By Product Type

• Programmable Implantable Pumps
• Non-Programmable Implantable Pumps
• Remote-Controlled Implantable Pumps
• Sensor-Enhanced Implantable Pumps
• Smartphone-Connected Implantable Pumps

By Application

• Pain Management
• Spasticity Management
• Oncology
• Gastroenterology
• Cardiology

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Online Stores
• Others

By Technology

• Bluetooth-enabled Implantable Pumps
• Wi-Fi-enabled Implantable Pumps
• RFID-enabled Implantable Pumps
• Near Field Communication (NFC) Implantable Pumps
• Wireless Charging Implantable Pumps

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson (Ethicon)
• Horizon Therapeutics
• Smiths Medical
• Bayer AG
• Teleflex Incorporated
• Fresenius Kabi AG
• Insulet Corporation
• Dexcom, Inc.
• Hälsokraft
• Flowonix Medical, Inc.
• Roche Diabetes Care
• Cambridge Medical Robotics